OpenAlex
PricingAboutJobs
Log inGet started
Work

Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells

HTML

Year: 2016
Type: article
Source: Cancer Research
DOI: 10.1158/0008-5472.can-15-1567
Authors: Deepak Mittal, Franco Caramia, Stefan Michiels, Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Christos Sotiriou, Sherene Loi, Mark J. Smyth
Institutions: The University of Queensland, QIMR Berghofer Medical Research Institute, The University of Melbourne, Peter MacCallum Cancer Centre, Université Paris-Sud, Inserm, Université Paris-Saclay, Institut Gustave Roussy, Centre de recherche en Epidémiologie et Santé des Populations, Fondation Gustave Roussy, University of Helsinki, Helsinki University Hospital, Tampere University Hospital, Université Libre de Bruxelles, Institut Jules Bordet
Language: English

Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: HER2-positive breast cancer, trastuzumab, IL-21, CD8+ T cells, trastuzumab resistance, tumor-infiltrating CD4+ T cells, combination chemotherapy, distant disease-free survival, metastasis
SDG: Good health and well-being

Open Access status: closed

Funder: QIMR Berghofer Medical Research Institute
OpenAlex ID: W2224619536
FWCI: 1.385
Cites: 51
Cited by: 33
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security